Australia's Sonic Healthcare rises as Citi upgrades to 'neutral', says outperforms industry hurdles

Shares of Australia's Sonic Healthcare SHL.AX rise as much as 2.1% to A$21.00, set for their best day since February 26, if gains hold

Citi upgrades the rating for Sonic Healthcare SHL.AX to "neutral" from "sell"

"Risk-reward looks more balanced," says Citi

Brokerage says the medical diagnostics services provider 'outperforms' industry backdrop in Australia in 1H26

But flags potential underperformance in the U.S. business, cost pressures for co, and lowers PT to A$21.5 from A$22

Five of 14 analysts rate the stock "buy" or higher, seven "hold" and two "sell" or lower; their median PT is A$25.3 – LSEG-compiled data

SHL stock down 8.9%, YTD